Indications And Dose
Maintenance treatment of chronic obstructive pulmonary disease ▶BY INHALATION OF POWDER ▶Adult: 150 micrograms once daily, then increased to 300 micrograms once daily
PDF page 287
Loading InternPractice…
Drug reference
Maintenance treatment of chronic obstructive pulmonary disease ▶BY INHALATION OF POWDER ▶Adult: 150 micrograms once daily, then increased to 300 micrograms once daily
PDF page 287
Convulsive disorders
PDF page 287
→Appendix 1: beta2 agonists
PDF page 287
▶Common or very common Chest pain. cough. increased risk of infection. muscle complaints. oropharyngeal pain. peripheral oedema. rhinorrhoea. throat irritation ▶Uncommon Diabetes mellitus. hypersensitivity. musculoskeletal pain. paraesthesia. skin reactions
PDF page 287
Manufacturer advises use only if potential benefit outweighs risk.
PDF page 287
Manufacturer advises avoid—present in milk in animal studies.
PDF page 287
Manufacturer advises caution in severe impairment (no information available).
PDF page 287
There can be variation in the licensing of different medicines containing the same drug. Inhalation powder ▶Onbrez Breezhaler (Novartis Pharmaceuticals UK Ltd) Indacaterol (as Indacaterol maleate) 150 microgram Onbrez Breezhaler 150microgram inhalation powder capsules with device | 30 capsule P £32.19 DT = £32.19 Indacaterol (as Indacaterol maleate) 300 microgram Onbrez Breezhaler 300microgram inhalation powder capsules with device | 30 capsule P £32.19 DT = £32.19 Combinations available: Glycopyrronium with indacaterol, p. 260 eiiii F 264
PDF pages 287, 288
Patients or carers should be given advice on how to administer indacaterol inhalation powder.
PDF page 287
150 micrograms once daily, then increased to
First-line fragment. Read the complete Indications and Dose section above.
PDF page 287